title: A different interpretation of the efficacy of lung cancer screening in the PLCO trial.
authors.affiliation: Department of Thoracic Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan. sagawam@kanazawa-med.ac.jp.
authors.forename: Motoyasu
authors.initials: M
authors.lastname: Sagawa
authors.affiliation: Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
authors.forename: Tomio
authors.initials: T
authors.lastname: Nakayama
authors.affiliation: Division of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.
authors.forename: Tomotaka
authors.initials: T
authors.lastname: Sobue
mesh_terms: D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000517:prevention & control*; D008297:Male; D008403:Mass Screening; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000517:prevention & control
keywords: Efficacy; Lung cancer screening; Mortality reduction; PLCO